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Abstract: Genome-wide association studies (GWAS) have been successful in detecting common genetic variants underlying common 
traits and diseases. Despite the GWAS success stories, the percent trait variance explained by GWAS signals, the so called “missing 
­ heritability”­has­been,­at­best,­modest.­Also,­the­predictive­power­of­common­variants­identified­by­GWAS­has­not­been­­ encouraging.­
Given these observations along with the fact that the effects of rare variants are often, by design, unaccounted for by GWAS and the 
availability of sequence data, there is a growing need for robust analytic approaches to evaluate the contribution of rare variants to 
  common complex diseases. Here we propose a new method that enables the simultaneous analysis of the association between rare and 
common variants in disease etiology. We refer to this method as SCARVA (simultaneous common and rare variants analysis). SCARVA is 
simple­to­use­and­is­efficient.­We­used­SCARVA­to­analyze­two­independent­real­datasets­to­identify­rare­and­common­variants­underlying­
variation in obesity among participants in the Africa America Diabetes Mellitus (AADM) study and plasma triglyceride levels in the 
  Dallas Heart Study (DHS). We found common and rare variants associated with both traits, consistent with published results.
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Introduction
Genome-wide  association  studies  (GWAS)  have 
proved­to­be­an­important­tool­for­the­identification­
of  common  genetic  variants  associated  with  many 
complex diseases and traits.1,2 Notably, however, the 
collection­of­variants­identified­so­far­through­GWAS­
explain  only  a  small  fraction  of  the  heritability 
estimated  from  family  studies  for  any  particular 
disease  or  trait.3,4  It  has  been  suggested  that  this 
“missing heritability” is due to the collective effects 
of rare variants which are usually unaccounted for in 
GWAS. The “rare variant hypothesis”5–7 proposes that 
a­significant­proportion­of­the­inherited­susceptibility­
to relatively common human chronic diseases may 
be due to the cumulative effects of a series of low 
frequency  dominantly  and  independently  acting 
variants at different genes, each conferring a moderate, 
but detectable, increase in relative risk. It is believed 
that  such  rare  variants  will  mostly  be  population-
specific,­ because­ of­ founder­ effects­ resulting­ from­
genetic drift. Data from published results show that the 
effects of rare variants tend to be larger than those of 
common variants. For example, only a handful of risk 
estimates for common variants (ie, frequency $5%) 
exceeds  2  with  the  majority  falling  between  1.1 
and  1.4.8,9  In  contrast,  rare  variants  tend  to  have 
risk estimates that are larger than 2. Moreover, it is 
believed that associated rare variants are more likely 
to be causal.7,9 A comprehensive review of current 
understanding  of  the  allelic  complexity  of  human 
disease genes is provided by Smith and Lusis.10 In 
addition, Bodmer and Bonilla7 provided a historical 
review­of­the­search­for­genetic­variants­influencing­
susceptibility of an individual to a chronic disease, 
from  R.A.  Fisher’s  seminal  work  to  the  current 
progress of whole-genome association studies.
The current thinking about the contribution of rare 
variants to complex diseases and traits has motivated 
the development of new analytic tools. Li and Leal11 
developed  combined  multivariate  and  collapsing 
and kernel based adaptive cluster methods to test for 
rare variant associations with complex traits. Price 
et al12 considered a method for the analysis of rare 
  variants. Other approaches have been proposed by 
Grady et al,13 Morris and Zeggini14 and Zhu et al.15 
McClellan  et  al16­ summarized­ evidence­ for­ rare­
alleles­responsible­for­Schizophrenia,­Shental­et­al17 
proposed a method based on compressed sequences. 
Notably,  all  of  these  approaches  are  based  on  the 
  separate  analysis  of    common  and  rare  variants. 
­ However,­we­believe­that­the­most­efficient­strategy­to­
localize­­ disease/trait­variants­will­involve­approaches­
that can identify both common and rare variants in 
the same model. Also, the method should distinguish 
between­ significant­ rare­ variants­ that­ increase­ risk­
and  those  that  are  protective.  We  present  such  an 
approach in this study.
The Method
Our method uses quantitative trait data with typed 
haplotypes and covariates from unrelated individuals. 
The  term  “rare  variant”  seems  to  lack  a  common 
definition;­some­define­it­as­a­variant­with­a­minor­
allele frequency less than 1%, but with non-negligible 
effect, residing in a functional unit, such as a gene.18 
Here­we­define­a­rare­variant­as­a­haplotype­with­
population  frequency  less  than  1%.  In  this  study, 
genomic­loci­(eg,­genes­or­chromosomes)­are­first­
partitioned­into­haplotypes,­defined­as­a­consecutive­
strings  of  SNPs  transmitted  together  from  parents 
to  offspring,  using  existing  methods  (for  example, 
HapLink, the HapMap website.19–21 The association 
of common haplotypes are modeled separately, while 
the  combined  association  of  all  rare  haplotypes  is 
modeled, to overcome the problem of a low number 
of  observations.  The  proposed  method  is  a  joint 
regression model with common and rare alleles as 
covariates, along with other covariates.
We refer to this method as SCARVA (simultaneous 
common and rare variants analysis).
Let Y = (y1, …, yn)′ be the quantitative traits of n 
unrelated individuals, with covariates X = (X1, …, Xn)′, 
where  each  Xi  is  a  row  vector  of  covariates,  and 
H = (h1, …, hn) is the observed haplotypes for the 
n individuals at a given genomic loci.   Suppose that in 
the population under consideration, there are m + l dif-
ferent haplotypes (or alleles, in a   simpler terminology) 
out of which hh
c
m
c
1 , …,   are common and hh
r
l
r
1 ,…,  rare. 
Each of the observedc or hi is one of the (, ) hh
c
m
c
1 …, : = Hc 
or one of (, ) hh
r
l
r
1 …, : = Hr (i = 1, … n). Let p = (p1, …, pm) 
and q = (ql, …, ql) be the   population frequencies of Hc 
and Hr respectively (note  i
m
i j
l
j pq
== ∑ + ∑ = 11 1). Since 
haplotypes  can  contain  several  SNPs,  the  computa-
tional   burden using haplotypes instead of individual 
SNPs­is­expected­to­be­several­fold­less;­however,­the­
results from SNP based analyses are likely to have Simultaneous analysis of common and rear variants
Bioinformatics and Biology Insights 2012:6  3
higher resolution. Also, as SNPs in a given haplotype 
tend to be transmitted together from parents to offspring, 
they are usually highly correlated to each other. Thus 
by searching for risk variants in a haplotype instead of 
individual SNPs, the proposed method (SCARVA) sig-
nificantly­reduces­computational­burden­several­fold­
depending­on­the­size­of­the­analysis­dataset.
A­ standard­ method­ of­ analyzing­ quantitative­
phenotype in the presence of covariates is regression. 
First,  we  describe  a  regression  model  in  which 
the effects of all rare alleles are modeled by a single 
parameter.  Due  to  the  expectation  that  some  rare 
variants will be positively associated, while others will 
be­inversely­associated,­we­first­identified­the­direction­
of the association (Step III below) in a single effect 
model and then modeled the positive and negative 
associations using different parameters. This modeling 
strategy­minimizes­the­loss­of­power­that­is­likely­to­
result from the single effect model and simultaneously 
analyzes­rare­variants­that­are­positively­and­negatively­
associated  with  the  underlying  trait(s).  Also,  the 
proposed  stepwise  regression  approach  effectively 
addresses  a  major  limitation  of  most  existing  rare 
variants  analysis,  which  is  the  combined  analysis 
of  non-functional  and  functional  variants  with  the 
resulting loss of statistical power.
Let I be the indicator function, the saturated model 
would be
 
yI hh Ih
Xi n
ii j
r
jj
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j
m
j
l
ii
=+ =+
++ ∈=
= = ∑ ∑ µλ α
β
() ()
,( ,, )
1 1
1 …
  (1)
where αj is the effect of j-th common allele hj
c;λ is 
the­cumulative­effect­of­the­rare­alleles­(haplotypes);­
β = (β1, …, βk)′ is the effect of the covariates, and the 
∈i’s are i.i.d. with E(∈i) = 0 and Var (∈i) = σ2, which is 
unknown and is estimated. Due to the fact that observed 
haplotypes are likely to be individually rare, we model 
the effects of all the rare variants with a single param-
eter λ (as in Morris and Zeggini).14 λ is approximately 
the mean effect of the individual effects λj’s
λλ ≈
= ∑ jj
j
l
qq /,
1
where qq j j
l
=
= ∑ .
1
To  simplify  notations,  let  α  = ( α1,  …,  αm), 
θ  = ( µ,  λ,  α,  β ′)′,  1n  =  (1,  …,  1)′  of  length  n, 
0n = (0, …, 0)′ of length n, In be the identity matrix of 
dimension n, Z = (1n, U, V, X), and ∈ = (∈1, …, ∈n)′, 
where  U  = ( u1,  …,  un)′,  V  = ( vij)1#i#n;1#j#l−1 
(note­for­each­fixed­i, we have 
j
l
ij v
= ∑ =
1 1, so we only 
use­the­first­l − 1status vij’s, otherwise the matrix Z′Z 
will be singular),  XX Xn = ′′ (,,) 1 … ', with
uI hhin vh h ii j
r
j
l
ij ij
c == == =
= ∑ () (, ,) () .
1
1 …  and 
Then (1) is re-written as
  YZ EV ar I nn =+ ∈∈ =∈ = θσ ,( ),() 0
2
  (2)
So­the­proposed­approach­for­the­identification­
of  common  and  rare  variants  that  are  associated 
with the trait of interest consists of several steps as 
  discribed below.
Step I. Fit the saturated model (2)
The least squares estimate  ˆ θ  of θ under model (2) is
1 ˆˆ ˆ ˆˆ (,, , ) ( ) ZZ ZY θ µλα β
− == ′ ′′ ′ ′
and the estimated variance is
2 2
1
1 ˆ ˆ ˆˆ ( ), ,
2
n
i ii
i
y yi y z
n
σβ
=
= −=
− ∑
where zi = (1, ui, vi,  ′ Xi) is the i-th row of Z, and vi is 
the i-th row of V.
Step II. Analysis of common risk allele(s)
Here­ we­ test­ the­ significance­ of­ the­ coefficient­
αj ( j  =  1,  …,  m)  of  each  allele  separately.  Of 
note,  the  least  squares  estimate  is  equivalent  to 
the  maximum    likelihood    estimate  under  the  nor-
mal model. Let φ (⋅) be the density function of the 
standard  normal  distribution,  and  l(θ)  be  the  log-
  likelihood of the data under φ (⋅). Denote the hypoth-
esis of no effect of the j-th common haplotype as 
Hj: αj = 0. Let Z−j = (1n, U, V−j, X) : = (z−j,1, …, z−j,n)′, 
where V−j is V with the j-th column removed, and 
let 
1 ˆˆ ˆ ˆˆ ( , , , )( ) j j j j j jj j ZZ ZY θ µλαβ
−
− − − − − −− − == ′′   be 
the least squares estimate of θ−j = (µ, λ, α−j, β ′)′ yuan et al
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under  Hj,  where  α−j  is  α  with  the  j-th  component 
removed, and the estimation of variance under Hj, is
2 2
, ,, 1
ˆ ˆˆ ( ), ˆ 1/ 2 θ σ − − −− = − −= =− ∑
n
i ji ji ji j i j yy y z n .
Let χ1
2 be the centered chisquared distribution with 
1 degree of freedom. If Hj true, then approximately
2 22
1 ˆˆ ˆˆ 2( ( , ) ( , )) ~ . θσ θ σ χ −− − jj ll
Given­a­significance­level­of­δ (often δ = 0.01, 
0.02 or 0.05), if
2 22
1 ˆˆ ˆˆ : 2( ( , ) ( , )) (1 ), j jj ll θσ θ σ χ δ −− Λ= − > −
we reject Hj. Where χ1
2(1 − δ) is the (1 − δ)-th upper 
quantile of χ1
2, we accept Hj.
After testing all the αj’s (j = 1, …, m), remove all 
the­non-significant­components­of­α (it is still denoted 
it as a to simplify notation). Let Hc be the collection 
of all the risk common haplotypes, and let V and Z 
denote their counterparts with the corresponding col-
umns­removed.­Re-fit­the­model­in­equation­(2)­with­
the current Z to get the new estimate of θ (still denoted 
as 
1 ˆ () ) ZZ ZY θ
− = ′′ .
Step III. Analysis of rare allele(s)
The risk rare alleles are of two types: alleles that are 
positively associated with the trait of interest (ie, con-
tributes positively to the effect λ), and alleles that are 
negatively associated with the trait (ie, contributes 
negatively to the effect of λ). Let R+ and R− denote 
the collection of these two types of rare variants in a 
given haplotype. We propose modeling the effects of 
the positive and negative rare variants using different 
coefficients.­First,­we­identify­the­rare­variants­in­R+ 
and R− respectively. To achieve this goal, we test the 
significance­of­each­rare­allele­hj
r and its effect based on 
the Z estimated from Step II. Let  ′ H j be the hypothesis: 
hj
r is non-risk. Similarly, let Z−j = (1n, U−j, V, X), where 
U−j  = (u−j,i,  …,  u−j,n)′u Ih hi n
ji kk j
l
ik
r
− =≠ = ∑ ==
, , () (, ,)
1 1… .   
Let  1 ˆˆ ˆ ˆˆ ( , , , )( ) j j j j j jj j ZZ ZY θ µλαβ
−
− − − − − −− − == ′′  be the
least  squares  estimate  of  θ  under  H′j,  and 
the  variance  under  H′j  can  be  estimated 
as 
2 2
, ,, 1
ˆ ( ), ˆ 1/ 2
n
i i ji ji j j i yy y z n θ σ − − −− − = −= ∑ = −   (the 
same  notation  was  used  in  Step  II).  In  this  step, 
however,  the  hypothesis  H′j  is  not  nested  within 
the full model, hence we cannot use the chisquare 
test as in step II. Instead we use a version of the 
Bayesian  information  criterion  (BIC).22  BIC  and 
the related AIC criteria have been used extensively 
in    statistical  applications.  Let  mj  be  the  number 
of  parameters  under  H  j′,  by  this  criterion.  Model 
under Hj′ is preferred if lm n jj j (, )/ )log( )   θσ −− −
2 2  is 
  largest among all j = 1, …, l. Here mj is the same 
for all j, thus, we pick the rare alleles hj
r’s as risk for 
those j’s where l jj (, )   θσ −−
2  is larger than the   others. 
Let δθ σθ σ jj j ll =− −− |(,)(, )|     22   (  j  =  1,…,  m),  and 
δδ =
−
= ∑ m j j
m 1
1 . We reject H′j if there is a big relative 
increase in δj, ie, if
 
j δ
δ
>γ.
Based  on  our  simulation  studies  and  with  the 
assumption that risk rear variants generally account 
for no more than 30% of all real variants), we rec-
ommend the following values for γ: γ = 1.1, 1.3 and 
1.5­to­represent­somewhat­significant,­significant­and­
very­significant.
If  hj
r­ is­ significant­ by­ the­ above­ method,­ and­
ˆˆ
j λλ − <  then removing hj
r resulted in underestimate 
of­the­total­effect;­thus­we­can­deduce­hR j
r ∈
+. If hj
r is 
not­significant,­then­hR j
r ∈
−.
Thus, we can identify all the positively and neg-
atively  associated  rare  variants  in  a  given  haplo-
type. Now let U = (U+, U−)′, with Uu un
++ + =(, ,) 1 …  
as  uI hhUu u i hR ij
r
n
j
r
+
∈ +
−− − == = ∑ () ,( ,,) 1 … as 
u Ih h i hR ij
r
j
r
−
∈ − ∑ = ()  V as after Step II, Z = (1n, U, V, X)′,   
λ = λ+, λ− and θ be the corresponding components 
for Z.
Note: if an analysis locus has only 1 rare allele, it 
may­not­be­meaningful­to­analyze­it­because­the­cor-
responding number of observations will be too few to 
make reliable conclusion.
Step IV. Fit the final model
Now with Z­from­Step­III,­we­re-fit­the­following­
model
  YZ =+ ∈ θ
The  least  squares  estimates  of  the  parameter 
1 ˆ ,() θθ
− = ′′ ZZ ZY,­ is­ the­ final­ characterization­ of­
the  associations  of  all  the  risk  rare  and  common 
variants.Simultaneous analysis of common and rear variants
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simulation study
We simulated a range of datasets with varied parame-
ter values and different numbers of variants, and used 
SCARVA­to­analyze­the­generated­data.­In­this­simu-
lation we sampled data sets based on a set of 4,000 
observed  quantitative  traits,  covariates,  and  corre-
sponding­alleles­within­a­given­haplotype­region;­for­
brevity, we present the results from one of these sim-
ulation exercises. We simulated observed haplotypes 
directly, without simulating genotypes and construct-
ing haplotypes by existing methods. The simulated 
haplotype­region­contained­20­alleles,­with­the­first­
10 designated as common and the last 10 as rare, with 
frequencies (p; q) = (p1, …, p10;­q1,...,q10) = (0.075, 
0.115, 0.130, 0.060, 0.220, 0.085, 0.105, 0.050, 0.015, 
0.095;­ 0.003,­ 0.007,­ 0.006,­ 0.004,­ 0.005,­ 0.004,­
0.006,  0.003,  0.005,  0.007). Among  the  rare  vari-
ants,­we­define­Hr = R+ ∪ R−, with  Rh hh
rrr + = {} 2310 ,,  
representing  all  positively  associated  rare  alleles, 
with  effects  λλλ 2310 04 5050 04 8
+++ ( ) = ,, (. ,. ,. );­ and­
Rh h
rr − = {} 58 ,  representing all negatively associated 
rare  alleles,  with  effects  λλ 58 05 30 49
−− ( ) =− − ,( ., .) . 
Thus  the  overall  effect  of  rare  variants  is 
λλ λλ
++ ++ =++= 23 10 2310 0 4755 qq qq qq // /.  and 
λλ λ
−− − =+ 58 58 qq qq // ;­let­λ = (λ+, λ−). Among the 
common­variants,­we­define­the­collection­of­risk­vari-
ants as Hh
cc = {} 3 , with effects α3 = 0.37, thus αj = 0 
(j ≠ 3). The covariates are X = (x1, x2, x3) =   (gender, 
age, body mass index [BMI]), where gender takes 
values 0 or 1 with probability 0.5 each, age in years 
is uniformly distributed [10,70], and BMI values are 
uniformly distributed (12,42). The effects of covari-
ates are β = (β1, β2, β3) = (0.0167, 0.008, 0.120). Given 
the haplotype and the covariates, the quantitative trait 
follows the normal N(1.5, 2) distribution.
For each of the individual observations ( )n = 2000 
yi’s), we generated haplotypes using the probabilities 
and covariates as described above. Using the simu-
lated data sets, we generated yi from (1) with µ = 1.5 
and σ  2 = 2. We then use the algorithms described in 
Steps I–IV to detect rare and common risk haplotypes. 
The results of these analyses for both the common and 
rare allele are displayed below (Table 1). As all the 10 
common alleles satisfy a linear constraint under the 
model,­we­only­show­the­results­for­the­first­9­alleles.­
For each common allele j, the Λj values and the corre-
sponding chisquare P-values in Step II are displayed 
to show how some common alleles are removed from 
the model. For each rare allele, the ratio δδ j /  in 
Step III are given to show how some rare alleles are 
removed from the model. Estimates of the regression 
parameters­in­the­final­model,­as­in­Step­IV,­(standard­
errors in brackets) are displayed in Table 1.
We­ correctly­ identified­ the­ common­ risk­ allele­
3  with  a  P-value­ of­ almost­ zero.­All­ other­ com-
mon alleles, simulated to be low-risk, are rejected. 
Table 1. Λ/P-values, δδ j / for each allele for simulated data.
common allele 1 2 3 4 5
Λj 0.80392 0.27248 1256.665 0.00985 0.78023
P-value 0.370 0.602 0.000 0.921 0.377
6 7 8 9 10
0.81300 0.33284 0.52457 0.12862
0.367 0.564 0.469 0.720
Rare allele 1 2 3 4 5
δδ j /
0.297 1.302 1.428 0.299 2.182
6 7 8 9 10
0.029 1.025 1.318 0.108 2.010
Parameter intercept α3 λ+ λ- bmi
real 0.800 0.017
estimates 1.505 0.806 0.545 −0.500 0.0173
(sd) (0.00033) (0.00015) (0.00034) (0.00057) (0.00001)
age gender
0.008 0.120
0.0077 0.128
(2.896e-6) (0.0001)yuan et al
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For  the  rare  alleles,  the  ratios  δδ j / ’s  of  alleles 
2, 3, 5, 8 and 10 are bigger than the critical value 
γ = 1.3, suggesting rare alleles 2, 3, 5, 8 and 10 are 
likely risk alleles. With the deletion of alleles 2,3, 
and 10, the estimates of λ were smaller, suggesting 
that these alleles are positively associated with the 
trait (ie, they belong to R+). Similarly, deleting alleles 
5 and 8 resulted in larger estimates of λ, suggesting 
that these two alleles are negatively associated with 
the trait and thus belong to R−. These results are con-
sistent with the ‘truth’ as implemented in our simu-
lated­dataset.­Finally,­we­refitted­the­model­with­only­
the associated (risk) common and rare alleles, as in 
the last three rows of Table 1, which also show the 
effects of the risk alleles with covariates included. 
Analyses of simulated data under different condi-
tions also reached the correct conclusions and are 
not displayed.
Real Data Analysis
We­used­SCARVA­to­analyze­two­independent­real­
datasets to identify rare and common variants under-
lying variation in obesity among participants in the 
Africa  America  Diabetes  Mellitus  (AADM)  study 
and  plasma  triglyceride  levels  in  the  Dallas  Heart 
Study (DHS).23 The software PHASE,24 was used to 
construct haplotypes. For both traits, our results were 
consistent with published results.
First real dataset
The AADM dataset included 141 unrelated individu-
als from West Africa who were part of a linkage and 
association study of type 2 diabetes (T2D) and asso-
ciated risk factors, including BMI, a commonly used 
measure of the degree of adiposity. The AADM proto-
col was approved by the institutional review board of 
Howard University and the respective institutions in 
West Africa. Written informed consent was obtained 
from each participant.
For this study we focused on the linkage and asso-
ciation signal observed in a 19cM region on chro-
mosome 5. After evidence for strong linkage in this 
region (125906 bp to 125960 bp) on chromosome 5, 
we­conducted­fine-mapping­using­experimentally­and­
imputed SNPs genotypes for an average map density 
of­less­than­1­kb.­The­results­of­the­fine-mapping­
(manuscript­in­preparation)­identified­a­very­strong­
candidate gene for obesity and this gene was sub-
sequently sequenced using Sanger technology. It is 
this­sequence­data­that­was­analyzed­using­SCARVA.­
Using an established method,25­we­identified­9­haplo-
type blocks in this gene. The results of the analyses 
of the haplotypes within these blocks using SCARVA 
were similar to those obtained using traditional meth-
ods, like logistic regression. Some numerical details 
of these results, including values of the correspond-
ing j’s, the log-likelihood, P-values and regression 
parameters (with standard errors) are displayed for 
the­first­haplotype­in­Table 2.
As shown in Table­2,­we­observed­a­significant­
(P = 0.023, from Step II) association between com-
mon­allele­1­with­BMI;­other­common­alleles­were­
not­significant­at­P = 0.05. The δδ j /  value (from 
Step III) for rare allele 3 was 4.205, which is much 
larger­than­the­suggested­highly­significant­critical­
value of γ = 2.5, indicating that rare allele 3 is strongly 
associated with obesity as measured by BMI. These 
results show that both common allele 1 and rare allele 
3 are strongly associated with obesity.
The overall results for all the nine haplotypes are 
summarized­in­Table 3 below. Displayed in the table 
are the number of common and rare haplotypes, the 
significant­ common­ allele­ with­ the­ corresponding­
P-value,­from­Step­II,­in­bracket,­and­the­significant­
Table 2. Λ/P-values δ δ j/  for each allele in block 1.
common allele 1 2 3 4 5 6
Λj 5.12324 0.70894 0.00744 0.82887 0.02079 0.02010
P-value 0.02361 0.39980 0.93128 0.36260 0.88534 0.88725
Rare allele 1 2 3 4 5
δδ j/
0.194 0.001 4.205 0.388 0.212
parameter intercept α1 λ age gender T2D
estimates 36.948 5.466 7.795 0.033 −1.860 −3.224
(sd) (0.167) (0.138) (0.217) (0.004) (0.038) (0.042)Simultaneous analysis of common and rear variants
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rare allele with the corresponding δδ j /  value, from 
Step III, in bracket, also by haplotype,
In  addition  to  the  results  described  above  for 
haplotype  1,  we  observed  that  common  allele  4 
(P-value = 0.027) and rare allele 2 (21 996 2 (/ .) δδ =  = 
1.996) are associated with obesity.
To  evaluate  our  real  dataset  and  compare  the 
results  to  those  obtained  from  SCARVA,  we  used 
QuTie26  approach  (the  Rare  Variant  Analysis  Tool 
for   Quantitative Trait). Notably, the QuTie method is 
designed to detect association of rare allele(s) only. It 
pools­the­low­frequency/rare­variants­within­defined­
regions and treats them as a single super locus, with 
analysis  by  linear  regression  and  student’s  t-test. 
Using haplotypes to pool rare variants, we observed 
a BMI value of 29.51 for QT + RV (the quantitative 
traits  for  individuals  with  at  least  one  rare  variant 
minor allele) compared to a mean of 23.71 for QT-RV 
(quantitative traits for individuals with no rare variant 
minor­allele;­P-value = 0.004, beta = −5.79, and std 
error = 1.98). These results indicate that rare variants 
are­associated­with­obesity,­although­the­specific­rare­
variant(s) responsible for the association is not neces-
sarily­­ identified.­In­contrast,­SCARVA­identified­rare­
allele 3 and common allele 1 as the likely risk alleles.
Second real dataset
The aim of the Dallas Heart Study23 was to use a 
reverse genetic strategy to test the hypothesis that 4 
angiopoietin-like proteins (ANGPTL 3, 4, 5 and 6) 
play  key  roles  in  triglyceride  (TG)  metabolism  in 
humans  by  re-sequencing  the  coding  regions  of 
the genes encoding these proteins. Analyses of the 
sequence­ data­ identified­ multiple­ rare­ nonsynony-
mous  (NS)  sequence  variants  that  were  associated 
with low plasma TG level but not with other   metabolic 
  phenotypes.  Functional  studies  revealed  that  all 
mutant alleles of ANGPTL 3 and ANGPTL 4 that were 
associated with low plasma TG level interfered either 
with the synthesis or secretion of the protein to inhibit 
lipoprotein lipase (LPL). Interestingly, a total of 1% 
of the DHS population and 4% of these participants 
with a plasma TG in the lowest quartile had a rare 
loss-of-function mutation in ANGPTL 3, ANGPTL 4, 
or  ANGPTL  5.  Hence  the  investigators  concluded 
that ANGPTL) 3, ANGPTL 4 and ANGPTL 5, but not 
ANGPTL 6, play non-redundant roles in TG metabo-
lism, and that multiple alleles at these loci cumula-
tively contribute to variability in plasma TG levels in 
human populations.
We­reanalyzed­the­DHS­sequencing­data­for­the­
three genes (ANGPTL 3, 4, 5) using SCARVA. The 
results­of­the­significant­common­and/or­rare­variants­
are displayed in Table 4. The displayed results include 
P-values, the δδ j/ ­values­for­the­significant­rare­vari-
ant and the number of total common variants and rare 
variants­along­with­the­coefficients­of­the­significant­
common/rare­variants­(with­standard­error).
Briefly,­the­results­of­our­reanalysis­using­SCARVA­
are as follows: we observed 2 common and 7 rare 
variants in ANGPTL 3 gene. The 2nd common variant 
is­significant­(P = 0.0461), the corresponding regres-
sion coeffcient is 0.027 with standard error 0.00017. 
The­2nd­and­4th­rare­variants­are­significant­with­
ratio δδ j/  values 1.916 and 1.376 respectively, and 
positive association of 0.218 (se 0.0009). The 6th rare 
variant with ratio value 2.7, is negatively associated 
with coeffcient −0.111 (SE 0.00017). We observed 2 
common and 27 rare variants in the ANGPTL 4 gene. 
None­of­the­common­variants­was­significantly­asso-
ciated with the trait. In contrast, rare variants 1, 13, 
14, 17 and 24 were negatively associated with the 
trait,­ with­ significant­ ratio­ values­ of­ 1.951,­ 2.260,­
9.236, 1.500, 2.670 respectively, and estimated effect 
of −0.0023 (0.000047). In the ANGPTL 5 gene, we 
observed 2 common and 19 rare variants. None of the 
common­variants­was­significantly­associated­with­
the trait. Rare variants 1 and 4 are positively asso-
ciated with the trait (ratio values 1.377 and 1.298 
respectively, and coeffcient 0.0960, se = 0.00039). 
Rare variants 7, 18 and 19 were negatively associated 
with the trait (ratio values of 1.961, 1.748 and 1.777, 
and with coeffcient −0.1376, se = 0.00057).
Table 3. Summary results for the AAdM data.
Block no. of  
comm. hap.
sig.  
P-value
no. of  
rare hap.
sig.  
ratio
1 7 1 (0.023) 5 3 (4.205)
2 2 2
3 7 4 (0.027) 2 2 (1.996)
4 2 2
5 8 3
6 2 2
7 3 1
8 2 1
9 2 1yuan et al
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Discussion
We proposed a novel approach (SCARVA) for the 
combined association analysis of common and rare 
variants  in  disease  and  non-disease  trait  research. 
SCARVA  is  a  regression-based  strategy  that  uses 
quantitative  trait  and  haplotype  data  together  with 
covariates. The common alleles analysis implemented 
in  SCARVA  is  a  straightforward  linear  regression. 
However, to avoid the problem of dimensionality (ie, 
large number of parameters with very small dataset), 
SCARVA models the effect of rare alleles using a 
single parameter with the well-developed approach 
of identifying variants that show positive as well as 
negative associations. Furthermore, we implemented 
the BIC and the AIC as test statistics, because the 
modeling  of  rare  alleles  is  partly  non-nested,  the 
classical chi-squared approach is not appropriate. In 
this regard, the rare variants analysis in SCARVA is 
less ‘quantitative’ than that of the common alleles. 
We note that, as implemented, SCARVA addresses 
a major limitation (ie, dilution of power due to the 
combined analysis of functional and non-functional 
variants) of current rare variants analysis software 
packages. Finally, we showed that the method is sim-
ple to use and computationally effcient. Simulation 
studies showed that the method works well and can 
accurately identify both the common and rare risk 
alleles­defined­as­those­variants­with­at­least­moderate­
effects on the trait.
In principle Step 2 and 3 can be done iteratively, 
but we prefer the current order of Step 2 then fol-
lowed by Step 3, as data on common alleles have 
more observations, and results inferred from them are 
more reliable than those from rare alleles. Thus we 
use the common alleles to guide the regressor selec-
tion in the model.
SCARVA uses haplotype information instead of 
individual  SNPs,  which  lowers  the  computational 
burden of the analysis. However, this computational 
advantage is at the cost of lower resolution. As part 
of future efforts in our lab, we are actively exploring 
how to extend SCARVA to accommodate the analysis 
of both haplotypes and individual SNPs. In this case 
synthetic association27,28 can be considered.
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